Idera Pharmaceuticals/ US45168K3068 /

1/17/2023 9:56:17 PM	Chg. -	Volume	Bid-	Ask-	High	Low
0.43USD	-	1,000 Turnover: 425	-Bid Size: -	-Ask Size: -	0.43	0.43

GlobeNewswire 12/14/2021 Idera Pharmaceuticals Announces Tilsotolimod Updates

GlobeNewswire 11/8/2021 Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire 9/7/2021 Passage Bio Announces Maxine Gowen, Ph.D., as Chairwoman of the Board of Directors

GlobeNewswire 8/9/2021 Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire 7/28/2021 BioCryst Appoints Vincent Milano to Board of Directors

GlobeNewswire 7/6/2021 Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officer

GlobeNewswire 6/4/2021 Kura Oncology Appoints Carol Schafer to Board of Directors

GlobeNewswire 5/18/2021 Idera Pharmaceuticals Announces Corporate Updates

GlobeNewswire 4/29/2021 Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire 4/5/2021 Vyant Bio Announces Newly Appointed Board of Directors

GlobeNewswire 3/18/2021 Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in an...

GlobeNewswire 3/18/2021 APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. a...

GlobeNewswire 3/1/2021 Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corpo...

GlobeNewswire 2/19/2021 Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors

GlobeNewswire 1/11/2021 Idera Pharmaceuticals to Present at Upcoming Conferences

GlobeNewswire 12/15/2020 Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20...

GlobeNewswire 11/17/2020 Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer

GlobeNewswire 10/29/2020 Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire 9/28/2020 Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037

GlobeNewswire 9/15/2020 Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020

GlobeNewswire 8/4/2020 Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire 7/15/2020 Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million

GlobeNewswire 6/2/2020 Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206...

GlobeNewswire 5/28/2020 Michael R. Dougherty Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of B...

GlobeNewswire 5/1/2020 Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of Stockholders